市場調查報告書
商品編碼
1411316
病理檢測設備市場:按設備、應用和最終用戶分類 - 2023-2030 年全球預測Pathology Instruments Market by Instruments (Centrifuges, Cytometers, Digital Pathology Solutions), Application (Anatomic Pathology, Clinical Pathology, Molecular Pathology), End-User - Global Forecast 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2022年病理檢測設備市場規模為70.3億美元,2023年達74.6億美元,預計2030年將達120.7億美元,複合年成長率為6.98%。
全球病理檢測設備市場
主要市場統計 | |
---|---|
基準年[2022] | 70.3億美元 |
預測年份 [2023] | 74.6億美元 |
預測年份 [2030] | 120.7億美元 |
複合年成長率(%) | 6.98% |
病理設備是用於檢查組織和體液以診斷疾病的專用工具和設備。這些儀器包括用於切片組織標本的切片機、用於對細胞和組織成分進行顏色編碼的組織染色系統以及用於測量特定血液和尿液樣本標記物的分析儀。病理檢測設備應用於組織病理學、細胞病理學、分子病理學、法醫病理學等領域。全球慢性病數量的不斷增加增加了對診斷服務的需求,因此需要引進高效的病理檢測設備。此外,增加政府在醫療保健方面的支出以及對實施先進病理學解決方案的支持將導致對病理設施的投資增加,從而促進市場成長。然而,先進病理檢測設備的高昂成本可能會阻礙普及。此外,與病理設備相關的錯誤和操作設備的困難可能對病理設備的普及構成進一步的挑戰。然而,為了改善和簡化病理設備的採用,主要企業正在投資將數位病理系統和設備與人工智慧和機器學習整合。這些系統可以處理大型資料集,提高診斷準確性並提高工作流程效率。此外,與醫療保健提供者合作開發將病理測試設備與其他醫療設備和電子健康記錄連接起來的整合系統可以為該行業開闢新的成長途徑。
區域洞察
以美國和加拿大為中心的美洲地區是醫療保健行業幾家主要公司的所在地,因此建立了強大的醫療保健基礎設施,從而推動了病理檢測設備市場的成長。該地區也不斷探索人工智慧(AI)、機器學習(ML)和巨量資料分析等先進數位技術,顯著提高病理設備的功能和性能。歐盟 (EU) 對體外診斷的嚴格監管和成熟的醫療基礎設施推動了市場的成長。私人和公共機構之間為提高診斷能力而進行的頻繁合作導致了病理解決方案和設備的持續創新。亞太地區病理檢測設備市場呈現快速成長,其中中國、日本和印度等國家引領擴張。由於大規模的醫療改革和醫療基礎設施投資的增加,中國市場正在經歷快速成長。此外,中國政府對公共衛生和預防保健措施的重視也刺激了病理服務需求的增加。
FPNV定位矩陣
FPNV定位矩陣對於評估病理檢測設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對病理實驗室設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-病理檢測設備市場的市場規模與預測是多少?
2-病理實驗室設備市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3-病理檢測設備市場的技術趨勢和法律規範是什麼?
4-病理檢測設備市場主要廠商的市場佔有率為何?
5-進入病理檢測設備市場合適的型態和策略手段是什麼?
[197 Pages Report] The Pathology Instruments Market size was estimated at USD 7.03 billion in 2022 and expected to reach USD 7.46 billion in 2023, at a CAGR 6.98% to reach USD 12.07 billion by 2030.
Global Pathology Instruments Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2022] | USD 7.03 billion |
Estimated Year [2023] | USD 7.46 billion |
Forecast Year [2030] | USD 12.07 billion |
CAGR (%) | 6.98% |
Pathology instruments are specialized tools and equipment used in the examination of tissues and body fluids to diagnose diseases. These instruments include microtomes for slicing tissue specimens, histology stain systems for color-coding cells and tissue components, and analyzers that measure specific blood or urine sample markers. Pathology instruments are applied in histopathology, cytopathology, molecular pathology, and forensic pathology, among other fields. An increase in chronic diseases worldwide contributes to the need for diagnostic services and necessitates the deployment of highly efficient pathology instruments. Furthermore, growing healthcare expenditure by governments and support for deploying advanced pathology solutions can lead to increased investments in pathology facilities, aiding the growth of the market. However, the high costs of advanced pathology instruments may hinder their adoption. Additionally, errors associated with pathology instruments and difficulties in handling the instruments can further present challenges to the widespread utilization of pathology instruments. However, key players are investing in the integration of digital pathology systems and instruments with AI, and machine learning offers to improve and ease the adoption of pathology instruments. These systems can handle large data sets, improve diagnostic accuracy, and enhance workflow efficiency. Furthermore, collaborating with healthcare providers to develop integrated systems that connect pathology instruments with other medical devices and electronic health records can provide new avenues of growth for the industry.
Regional Insights
The Americas region, particularly the US and Canada, features a robust healthcare infrastructure characterized by the presence of several major players in the healthcare industry, which has driven the growth of the pathology instruments market. The region is also involved in the constant exploration of advanced digital technologies, including artificial intelligence (AI), machine learning (ML), and big data analytics, that have significantly enhanced the functionality and performance of pathology instruments. Stringent regulations by the European Union on in-vitro diagnostics and a well-established healthcare infrastructure foster market growth. Frequent collaboration between private and public entities to propel diagnostics capabilities has further led to constant innovations in pathology solutions and instruments. The Asia-Pacific region is exhibiting rapid growth in the pathology instruments market, with countries such as China, Japan, and India leading the expansion. China's market is burgeoning, fueled by large-scale healthcare reforms and growing investment in healthcare infrastructure. Additionally, the Chinese government's focus on public health and preventive healthcare measures adds to the increased demand for pathology services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pathology Instruments Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pathology Instruments Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Amos Scientific Pty. Ltd., Becton, Dickinson and Company, Bio SB Inc., Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Carl Zeiss AG, Danaher Corporation, Diapath S.p.A., Diatron Group by STRATEC SE, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Hamamatsu Photonics K.K., Hamilton Company, Hologic, Inc., Horiba Corporation, Illumina Inc., Jinan Olabo Technology Co., Ltd., Koninklijke Philips N.V., Merck KGaA, Mikroscan Technologies, Inc., Nihon Kohden Corporation, Olympus Corporation, PerkinElmer Inc., PHC Holdings Corporation, QIAGEN N.V., RWD Life Science Co., Ltd., Sakura Finetek Japan Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., VOGEL MedTec GmbH, and Waters Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pathology Instruments Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pathology Instruments Market?
3. What are the technology trends and regulatory frameworks in the Pathology Instruments Market?
4. What is the market share of the leading vendors in the Pathology Instruments Market?
5. Which modes and strategic moves are suitable for entering the Pathology Instruments Market?